Navigation Links
Ghengis Khan wonder berry could conquer heart disease

Berries taken since the time of Ghengis Khan could form the basis of the next big thing in heart health. Sea buckthorn is a known source of biologically active chemicals and is used in Tibet, Mongolia, China and Russia for health drinks and various cosmetics. Juice extracted using current methods is of poor quality, but scientists in India have developed a highly efficient technique to extract large quantities of cholesterol-lowering compounds. Two companies have shown interest in the process including one based in Mongolia.

In research due to be published this week in SCI's Journal of the Science of Food and Agriculture (DOI 10.1002/jsfa2620) Dr C Arumyghan and his team at the Regional Research Laboratory, Trivandrum report the implementation of a new process which retains more than 40% of polyphenols - the same beneficial chemicals found in red wine, 50% of flavonoids and 70% of vitamin C present in the pulp of the red berries.

Antioxidants in the berries inhibit so-called 'bad' LDL cholesterol oxidisation, which could provide a new weapon to fight cardiovascular disease. When LDL cholesterol is oxidized, it sticks to the lining of blood vessels. Consuming the berries in food or drinks is expected to prevent the arteries from clogging up.

Arumughan is confident that this technology had great potential, saying "No previous report has shown efficiency matching ours". Arumughan's team have unlocked the nutrients by applying novel processing technique for the first time. The key to their success is using continuous high speed centrifugation (spinning) to separate the juice and the solid sludge.

Source:Society of Chemical Industry

Page: 1

Related biology news :

1. Give thanks for the cranberry, say dental researchers
2. Strawberry daiquiris -- the extra-healthy cocktail?
3. Protein discovery could unlock the secret to better TB treatment
4. Tiny particles could solve billion-dollar problem
5. First atlas of key brain genes could speed research on cancer, neurological diseases
6. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
7. A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
8. How the environment could be damaging mens reproductive health
9. Dead zone area in Gulf could be increasing, researchers say
10. Growth in biomass could put US on road to energy independence
11. Nano-bumps could help repair clogged blood vessels
Post Your Comments:

(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... subsidiary of Infosys (NYSE: INFY ), and Samsung ... global partnership that will provide end customers with a ... and payment services.      (Logo: ... for financial services, but it also plays a fundamental part ...
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
Breaking Biology Technology: